Claims for Patent: 6,476,005

Summary for Patent: 6,476,005

Title:	Oral and injectable nutritional composition
Abstract:	An oral and injectable composition for mammals comprising a salt of glucosamine, such as glucosamine hydrochloride, sulfate, nitrate, or iodide, a chondroitin sulfate, hydrolyzed or native collagen, a sodium hyaluronate, chelated manganese ascorbate, and L-malic acid in powder form for oral ingestion or in a solution of sterilized water for injection. The composition acts as a chondroprotective agent which provides foundational support for the creation of new body tissue and cartilage growth in humans and animals. Other beneficial physiological properties include the enhancement of chondrocyte synthesis, the healing of chronic or acute wounds, the maintenance of healthy muscle and tissue, increasing the desirable concentration of hyaluronic acid, and anti-inflammatory activity.
Inventor(s):	Petito; George D. (Bethlehem, PA), Petito; Anita M. (Bethlehem, PA)
Assignee:
Application Number:	09/360,169
Patent Claims:	1. An orally ingestible composition for use in mammals consisting of the following ingredients in mg/kg of bodyweight: a glucosamine salt in a range of about 2-10 mg/kg, said glucosamine salt being selected from the group consisting of hydrochloride, sulfate, nitrate, and iodide; chondroitin sulfate in a range of about 1-8 mg/kg; hydrolyzed collagen in a range of about 2-20 mg/kg; sodium hyaluronate in a range of about 1-7 mg/kg; a chelated manganese salt in a range of about 0.5-3 mg/kg; and L-malic acid in a range of about 0.2-6 mg/kg, said L-malic acid acting as a detoxifying agent. 2. The composition according to claim 1, wherein the hydrolyzed collagen is hydrolyzed Type 1 collagen having an average molecular weight of about no greater than 2,000 Daltons. 3. The composition according to claim 2, wherein the hydrolyzed collagen is hydrolyzed Type 1 collagen having an average molecular weight of about no greater than 1,500 Daltons. 4. The oral nutritional powder composition according to claim 1, wherein the ingredients have the following ranges in mg/kg of bodyweight: 3-8 mg/kg of glucosamine salt; 1-6 mg/kg of chondroitin sulfate; 3-15 mg/kg of hydrolyzed collagen; 2-6 mg/kg of sodium hyaluronate; 0.5-1 mg/kg of manganese ascorbate; and 0.2-1 mg/kg of L-malic acid. 5. The composition according to claim 1, wherein the composition is a dosage form selected from the group consisting of a powder, capsule or tablet. 6. An injectable composition for use in mammals consisting of the following ingredients in an aqueous solution in mg/kg of bodyweight: a glucosamine salt in a range of 2-10 mg/kg, said glucosamine salt being selected from the group consisting of hydrochloride, sulfate and nitrate; chondroitin sulfate in a range of 1-8 mg/kg; hydrolyzed collagen in a range of 2-20 mg/kg; sodium hyaluronate in a range of 1-7 mg/kg; a chelated manganese salt in a range of 0.5-3 mg/kg; L-malic acid in a range of about 0.2-6 mg/kg, said L-malic. acid acting as a detoxifying agent; and sterile water. 7. The injectable composition according to claim 6, wherein the hydrolyzed collagen is hydrolyzed Type 1 collagen having an average molecular weight of about no greater than 2,000 Daltons. 8. The injectable composition according to claim 6, wherein the hydrolyzed collagen is hydrolyzed Type 1 collagen having an average molecular weight of about no greater than 1,500 Daltons. 9. The injectable composition according to claim 6, wherein the ingredients have the following ranges in mg/kg of bodyweight: 3-8 mg/kg of glucosamine salt; 1-6 mg/kg of chondroitin sulfate; 3-15 mg/kg of hydrolyzed collagen; 2-6 mg/kg of sodium hyaluronate; 0.5-1 mg/kg of manganese ascorbate; and 0.2-1 mg/kg of L-malic acid.

Details for Patent 6,476,005

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2018-03-24